Netherlands· NL-14d43e8ec199
Daybu 200 mg/ml drank
A trofinetide product containing trofinetide + trofinetide + trofinetide x-water, registered in Netherlands by Acadia Pharmaceuticals (Netherlands) B.V.. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Trofinetide is registered in 7 of 19 countries.
Countries holding a registration under ATC N07XX24 (trofinetide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Trofinetide · ATC N07XX24
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TROFINETIDE + TROFINETIDE + TROFINETIDE X-WATER
- Manufacturer
- Acadia Pharmaceuticals (Netherlands) B.V.
- Country
- Netherlands (NL)
- ATC code
- N07XX24
- ATC class
- Trofinetide
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/26/2045
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N07XX24
Trofinetide, as other registers publish it.
- FinlandDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- DenmarkDaybuAcadia Pharmaceuticals (Netherlands) B.V.
- CzechiaDAYBUAcadia Pharmaceuticals (Netherlands) B.V., Amsterdam
- BelgiumDaybu 200 mg/mlAcadia Pharmaceuticals (Netherlands)
- United StatesDaybueAcadia Pharmaceuticals Inc.
- United StatesDaybueAcadia Pharmaceuticals Inc.
- United StatesDaybueAcadia Pharmaceuticals Inc.
- CanadaDAYBUEACADIA PHARMACEUTICALS INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbc6c9f4-427d-47e6-b188-ecd64399aefc GET /v1/drugs/cbc6c9f4-427d-47e6-b188-ecd64399aefc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Drank",
"route": "Oraal gebruik, Gastro-enteraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/daybu-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Trofinetide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134573",
"excipients": [
"AARDBEIENSMAAKSTOF",
"ALLURAROOD AC (E 129)",
"MALTITOL (E 965)",
"NATRIUMMETHYLPARAHYDROXYBENZOAAT (E 219)",
"NATRIUMPROPYLPARAHYDROXYBENZOAAT",
"PROPYLEENGLYCOL (E 1520)",
"SUCRALOSE (E 955)",
"WATER, GEZUIVERD"
],
"substances": [
"TROFINETIDE",
"TROFINETIDE",
"TROFINETIDE X-WATER"
],
"leaflet_url": null,
"authorised_at": "2026/08/20",
"procedure_number": "EMEA/H/C/006482",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/26/2045",
"additional_monitoring": "Y"
}See everything about trofinetide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.